Cite
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes [corrected] [published erratum appears in CLIN THER 2006 Nov;28(11):1967].
MLA
Philis-Tsimikas A, et al. “Comparison of Once-Daily Insulin Detemir with NPH Insulin Added to a Regimen of Oral Antidiabetic Drugs in Poorly Controlled Type 2 Diabetes [Corrected] [Published Erratum Appears in CLIN THER 2006 Nov;28(11):1967].” Clinical Therapeutics, vol. 28, no. 10, Oct. 2006, pp. 1569–81. EBSCOhost, https://doi.org/10.1016/j.clinthera.2006.10.020.
APA
Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, & Thorsteinsson B. (2006). Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes [corrected] [published erratum appears in CLIN THER 2006 Nov;28(11):1967]. Clinical Therapeutics, 28(10), 1569–1581. https://doi.org/10.1016/j.clinthera.2006.10.020
Chicago
Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, and Thorsteinsson B. 2006. “Comparison of Once-Daily Insulin Detemir with NPH Insulin Added to a Regimen of Oral Antidiabetic Drugs in Poorly Controlled Type 2 Diabetes [Corrected] [Published Erratum Appears in CLIN THER 2006 Nov;28(11):1967].” Clinical Therapeutics 28 (10): 1569–81. doi:10.1016/j.clinthera.2006.10.020.